MC Services: experts in corporate communications and investor relations
5
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-5,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,qode-restaurant-1.0,tribe-no-js,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-13.0,qode-theme-bridge,bridge-child,wpb-js-composer js-comp-ver-5.4.4,vc_responsive

MC Services is an international Corporate Communications and Investor Relations firm providing Life Sciences companies high-level consultancy, targeted services and support throughout Europe and beyond

Our Services

CORPORATE COMMUNICATIONS

Designing, implementing and effectively operating international Corporate Communications programs is part of our core expertise.

INVESTOR RELATIONS

Our trained senior Investor Relations specialists provide a unique opportunity to have immediate access to the necessary tools, skills and networks you need in Europe, the UK and the US.

ROADSHOWS & TRANSACTIONS

We target the appropriate audience for the unique investment proposition of your Company and help raise capital through IPOs, secondary offerings or other equity financings.  

CLIENT REFERENCES

MEET US @

BIO-Europe // November 5–7, 2018, Copenhagen, Denmark

German Equity Forum // November 26-28, 2018, Frankfurt

Scrip Awards 2018 // November 28, London, UK

Our News

MC Services AG
@MCServicesAGAug 20
RT @BioCentury: Motif's antibiotic gets Priority Review https://t.co/14SnRbaH5J
MC Services AG
@MCServicesAGAug 20
RT @EPM_Magazine: #FDA accepts new drug application for #iclaprim https://t.co/TAnzBf8iej @MotifBio @EPM_Magazine #NDA #ABSSSI https://t.co
MC Services AG
@MCServicesAGAug 20
RT @TransgeneSA: @TransgeneSA completes the sale of the Greater China rights of TG6002 and TG1050 to Tasly Biopharmaceuticals for $48 milli…